{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:30:36Z","timestamp":1772825436962,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.msard.2024.106237","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T08:10:40Z","timestamp":1734336640000},"page":"106237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["MicroRNA frontiers: Illuminating early detection paths in multiple sclerosis"],"prefix":"10.1016","volume":"95","author":[{"given":"Mahdi","family":"Mohseni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazal","family":"Behzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Behroozi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamraz","family":"Mohseni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-9576","authenticated-orcid":false,"given":"Behnaz","family":"Valipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11033-022-07905-0","article-title":"MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose","volume":"50","author":"Abolghasemi","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-13-33","article-title":"Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128","volume":"13","author":"Adlakha","year":"2014","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.msard.2024.106237_bib0003","first-page":"161","article-title":"The role of microRNAs in human diseases","volume":"2","author":"Ardekani","year":"2010","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"10.1016\/j.msard.2024.106237_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2021.10.004","article-title":"Laboratory biomarkers of multiple sclerosis (MS)","volume":"99","author":"Arneth","year":"2022","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.msard.2024.106237_bib0005","article-title":"MicroRNA targeting: a novel therapeutic intervention for ovarian cancer","volume":"35","author":"Asl","year":"2023","journal-title":"Biochem. Biophys. Rep."},{"issue":"9","key":"10.1016\/j.msard.2024.106237_bib0007","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/01616412.2021.1935099","article-title":"Expression levels of IL-17\/IL-23 cytokine-targeting microRNAs 20, 21, 26, 155, and Let-7 in patients with relapsing-remitting multiple sclerosis","volume":"43","author":"Balkan","year":"2021","journal-title":"Neurol. Res."},{"issue":"1 (28)","key":"10.1016\/j.msard.2024.106237_bib0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.32607\/20758251-2016-8-1-21-33","article-title":"MicroRNAs: the role in autoimmune inflammation","volume":"8","author":"Baulina","year":"2016","journal-title":"Acta Naturae (\u0430\u043d\u0433\u043b\u043e\u044f\u0437\u044b\u0447\u043d\u0430\u044f \u0432\u0435\u0440\u0441\u0438\u044f)"},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0009","article-title":"Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis","volume":"3","author":"Bergman","year":"2016","journal-title":"Neurology-Neuroimmunol. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.msard.2024.106237_bib0010","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1212\/WNL.0000000000002975","article-title":"Should the symptomatic region be included in dissemination in space in MRI criteria for MS?","volume":"87","author":"Brownlee","year":"2016","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.msard.2024.106237_bib0011","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1159\/000491543","article-title":"The role of MiR-132 in regulating neural stem cell proliferation, differentiation and neuronal maturation","volume":"47","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0012","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1172\/JCI88415","article-title":"Excessive expression of miR-27 impairs Treg-mediated immunological tolerance","volume":"127","author":"Cruz","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0013","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/ijms23031664","article-title":"Differential expression of serum extracellular vesicle miRNAs in multiple sclerosis: disease-stage specificity and relevance to pathophysiology","volume":"23","author":"Cuomo-Haymour","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2024.106237_bib0014","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.msard.2018.09.041","article-title":"Effectiveness and safety of Rituximab in demyelinating diseases spectrum: an Italian experience","volume":"27","author":"D'Amico","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2024.106237_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.autrev.2019.05.003","article-title":"Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: present and future perspectives","volume":"18","author":"D'Amico","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0016","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s00415-022-11391-6","article-title":"MicroRNAs 181a and 125a are highly expressed in na\u00efve RRMS: a pilot case\u2013control study","volume":"270","author":"D'Amico","year":"2023","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.106237_bib0017","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/genes5040865","article-title":"The role of microRNAs in mitochondria: small players acting wide","volume":"5","author":"Duarte","year":"2014","journal-title":"Genes. (Basel)"},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0018","first-page":"127","article-title":"Identification of miR-24 and miR-137 as novel candidate multiple sclerosis miRNA biomarkers using multi-staged data analysis protocol","volume":"6","author":"Ehya","year":"2017","journal-title":"Mol. Biol. Res. Commun."},{"key":"10.1016\/j.msard.2024.106237_bib0019","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12264-017-0153-y","article-title":"MiR-30a positively regulates the inflammatory response of microglia in experimental autoimmune encephalomyelitis","volume":"33","author":"Fang","year":"2017","journal-title":"Neurosci. Bull."},{"issue":"11","key":"10.1016\/j.msard.2024.106237_bib0020","doi-asserted-by":"crossref","first-page":"e79416","DOI":"10.1371\/journal.pone.0079416","article-title":"Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia","volume":"8","author":"Freilich","year":"2013","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNa"},{"key":"10.1016\/j.msard.2024.106237_bib0022","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2021.01.020","article-title":"MicroRNA in multiple sclerosis","volume":"516","author":"Gao","year":"2021","journal-title":"Clinica Chimica Acta"},{"issue":"5","key":"10.1016\/j.msard.2024.106237_bib0023","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/jpm12050770","article-title":"Dysregulated miRNAs as biomarkers and therapeutical targets in neurodegenerative diseases","volume":"12","author":"Gentile","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.msard.2024.106237_bib0024","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2018.03.035","article-title":"Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+ T lymphocytes of relapsing-remitting multiple sclerosis patients","volume":"659","author":"Ghadiri","year":"2018","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0404.2010.01444.x","article-title":"Pathophysiology of multiple sclerosis and the place of teriflunomide","volume":"124","author":"Gold","year":"2011","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0026","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/resp.13756","article-title":"Molecular techniques for respiratory diseases: microRNA and extracellular vesicles","volume":"25","author":"Gon","year":"2020","journal-title":"Respirology."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0027","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-023-02811-z","article-title":"miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod","volume":"20","author":"Gonzalez-Martinez","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2024.106237_bib0028","unstructured":"Guan Y., Jakimovski D., Ramanathan M., Weinstock-Guttman B., Zivadinov R. The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to. vivo."},{"issue":"1\u20132","key":"10.1016\/j.msard.2024.106237_bib0029","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2011.10.006","article-title":"miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing","volume":"248","author":"Guerau-de-Arellano","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.msard.2024.106237_bib0030","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1007\/s11033-021-06616-2","article-title":"Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer","volume":"48","author":"Gunel","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"7","key":"10.1016\/j.msard.2024.106237_bib0031","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ddr.21277","article-title":"Targeting microRNAs in prevention and treatment of neurodegenerative disorders","volume":"76","author":"Gupta","year":"2015","journal-title":"Drug Dev. Res."},{"issue":"11\u201312","key":"10.1016\/j.msard.2024.106237_bib0032","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/13524585231195346","article-title":"Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: the ALITHIOS open-label extension","volume":"29","author":"Hauser","year":"2023","journal-title":"Multiple Scler. J."},{"issue":"8","key":"10.1016\/j.msard.2024.106237_bib0033","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.1502562","article-title":"MerTK is a functional regulator of myelin phagocytosis by human myeloid cells","volume":"196","author":"Healy","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2024.106237_bib0034","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pneurobio.2016.06.005","article-title":"MicroRNA: small RNA mediators of the brains genomic response to environmental stress","volume":"143","author":"Hollins","year":"2016","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.msard.2024.106237_bib0035","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/etm.2017.4410","article-title":"Multiple sclerosis: pathology, diagnosis and treatments","volume":"13","author":"Huang","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"9","key":"10.1016\/j.msard.2024.106237_bib0036","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/brainsci8090177","article-title":"Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches","volume":"8","author":"Hussain","year":"2018","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0037","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/acn3.152","article-title":"Natalizumab restores aberrant mi RNA expression profile in multiple sclerosis and reveals a critical role for miR-20b","volume":"2","author":"Ingwersen","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2024.106237_bib0038","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00415-019-09489-5","article-title":"A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition","volume":"268","author":"Inojosa","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.106237_bib0039","doi-asserted-by":"crossref","DOI":"10.1177\/11772719211013352","article-title":"Multiple sclerosis biomarker discoveries by proteomics and metabolomics approaches","volume":"16","author":"Jafari","year":"2021","journal-title":"Biomark. Insights."},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2938","article-title":"Immune cell regulation by autocrine purinergic signalling","volume":"11","author":"Junger","year":"2011","journal-title":"Nature Rev. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0041","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1352458513496343","article-title":"Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing","volume":"20","author":"Keller","year":"2014","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.msard.2024.106237_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106377","article-title":"Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2\u2032-deoxyguanosine in patients with multiple sclerosis","volume":"200","author":"Khajenobar","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"9","key":"10.1016\/j.msard.2024.106237_bib0043","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028928","article-title":"Clinical course of multiple sclerosis","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.msard.2024.106237_bib0044","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fneur.2020.00288","article-title":"The regulation of microRNAs in Alzheimer's disease","volume":"11","author":"Kou","year":"2020","journal-title":"Front. Neurol."},{"issue":"40","key":"10.1016\/j.msard.2024.106237_bib0045","doi-asserted-by":"crossref","first-page":"42230","DOI":"10.1074\/jbc.M404931200","article-title":"Structural features of microRNA (miRNA) precursors and their relevance to miRNA biogenesis and small interfering RNA\/short hairpin RNA design","volume":"279","author":"Krol","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0046","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40265-022-01672-9","article-title":"Ocrelizumab: a review in multiple sclerosis","volume":"82","author":"Lamb","year":"2022","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0047","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","article-title":"Altered microRNA regulation in Huntington's disease models","volume":"227","author":"Lee","year":"2011","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.106237_bib0048","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI94012","article-title":"miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity","volume":"127","author":"Li","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.msard.2024.106237_bib0049","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1002\/mgg3.1189","article-title":"MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease","volume":"8","author":"Li","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.msard.2024.106237_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.744942","article-title":"MicroRNAs Play a Role in Parkinson's Disease by Regulating Microglia Function: from Pathogenetic Involvement to Therapeutic Potential","volume":"14","author":"Li","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.msard.2024.106237_bib0051","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.gpb.2012.07.005","article-title":"MicroRNAs in common human diseases","volume":"10","author":"Li","year":"2012","journal-title":"Genomics Proteomics Bioinf."},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0052","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/cells11030572","article-title":"The biogenesis of miRNAs and their role in the development of amyotrophic lateral sclerosis","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0053","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.106237_bib0054","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12859-018-2518-2","article-title":"Identification of pre-microRNAs by characterizing their sequence order evolution information and secondary structure graphs","volume":"19","author":"Ma","year":"2018","journal-title":"BMC Bioinf."},{"issue":"9","key":"10.1016\/j.msard.2024.106237_bib0055","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.3390\/ijms22094332","article-title":"Saluk-Bijak J. miR-155 as an important regulator of multiple sclerosis pathogenesis. A review","volume":"22","author":"Maciak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.msard.2024.106237_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157153","article-title":"Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients","volume":"11","author":"Mameli","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2024.106237_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0504-2","article-title":"MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression","volume":"13","author":"Mancuso","year":"2015","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0058","first-page":"1","article-title":"Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a\/b in patients with multiple sclerosis and active lesions","volume":"16","author":"Mart\u00edn","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2024.106237_bib0059","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fimmu.2018.00490","article-title":"Experimental demyelination and axonal loss are reduced in MicroRNA-146a deficient mice","volume":"9","author":"Martin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2024.106237_bib0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-981-10-5987-2_5","article-title":"miR-155 dysregulation and therapeutic intervention in multiple sclerosis","author":"McCoy","year":"2017","journal-title":"Regul. Inflammatory Signaling Health Dis."},{"issue":"5","key":"10.1016\/j.msard.2024.106237_bib0061","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.106237_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103835","article-title":"miRNAs in multiple sclerosis: a clinical approach","volume":"63","author":"Minutti-Zanella","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0063","doi-asserted-by":"crossref","first-page":"e24170","DOI":"10.1002\/jcla.24170","article-title":"Investigation of serum levels of orexin-A, transforming growth factor \u03b2, and leptin in patients with multiple sclerosis","volume":"36","author":"Moharami","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"5","key":"10.1016\/j.msard.2024.106237_bib0064","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.23967","article-title":"miR-155 as a multiple sclerosis\u2013relevant regulator of myeloid cell polarization","volume":"74","author":"Moore","year":"2013","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.106237_bib0065","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00277-021-04573-1","article-title":"Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study","volume":"100","author":"Motaei","year":"2021","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0066","article-title":"miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis","volume":"10","author":"Mu\u00f1oz-San Mart\u00edn","year":"2023","journal-title":"Neurol."},{"issue":"29","key":"10.1016\/j.msard.2024.106237_bib0067","doi-asserted-by":"crossref","first-page":"11964","DOI":"10.1073\/pnas.1311087110","article-title":"Aryl hydrocarbon receptor-mediated induction of the microRNA-132\/212 cluster promotes interleukin-17\u2013producing T-helper cell differentiation","volume":"110","author":"Nakahama","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.msard.2024.106237_bib0068","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/jcm4081651","article-title":"MicroRNA processing and human cancer","volume":"4","author":"Ohtsuka","year":"2015","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.msard.2024.106237_bib0069","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1177\/1352458517729465","article-title":"Clinical outcome measures for progressive MS trials","volume":"23","author":"Ontaneda","year":"2017","journal-title":"Multiple Sclerosis J."},{"issue":"5","key":"10.1016\/j.msard.2024.106237_bib0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrn3722","article-title":"Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease","volume":"15","author":"Prinz","year":"2014","journal-title":"Nature Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0071","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s43042-024-00543-0","article-title":"miR-146a and miR-155 as promising biomarkers for prognosis and diagnosis of multiple sclerosis: systematic review","volume":"25","author":"Rajabi","year":"2024","journal-title":"Egypt. J. Medical Human Genet."},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0072","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41582-023-00776-4","article-title":"Origins and immunopathogenesis of autoimmune central nervous system disorders","volume":"19","author":"Ramanathan","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2024.106237_bib0073","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fnmol.2016.00128","article-title":"Role of microRNAs in the regulation of \u03b1-synuclein expression: a systematic review","volume":"9","author":"Recasens","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.msard.2024.106237_bib0074","first-page":"e491","article-title":"Identification of MS-specific serum miRNAs in an international multicenter study","volume":"5","author":"Regev","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.106237_bib0075","doi-asserted-by":"crossref","unstructured":"Reich D., Lucchinetti C., Calabresi P. CAS: 528: DC% 2BC1MXhtFKmsbo% 3D. Multiple Scler.. 378(2):169\u201380.","DOI":"10.1056\/NEJMra1401483"},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0076","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nature Rev. Drug discovery"},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0077","doi-asserted-by":"crossref","first-page":"e30832","DOI":"10.1371\/journal.pone.0030832","article-title":"MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state","volume":"7","author":"Saba","year":"2012","journal-title":"PLoS. One"},{"issue":"12","key":"10.1016\/j.msard.2024.106237_bib0078","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrn2763","article-title":"microRNAs at the synapse","volume":"10","author":"Schratt","year":"2009","journal-title":"Nature Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.msard.2024.106237_bib0079","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ana.24931","article-title":"Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis","volume":"81","author":"Selmaj","year":"2017","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/2211536611666220928154015","article-title":"MicroRNAs as a new target for Alzheimer's disease treatment","volume":"12","author":"Shademan","year":"2023","journal-title":"Microrna"},{"key":"10.1016\/j.msard.2024.106237_bib0081","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12017-020-08601-7","article-title":"Application of next-generation sequencing in neurodegenerative diseases: opportunities and challenges","volume":"23","author":"Shademan","year":"2021","journal-title":"Neuromol. Med."},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0082","doi-asserted-by":"crossref","first-page":"168","DOI":"10.52547\/jarums.22.2.168","article-title":"Investigating the Expression level of miRNA-21, miRNA-155, miRNA-182, and miRNA-437 along with Inflammatory Markers in Cerebrospinal Fluid of Patients with Multiple Sclerosis","volume":"22","author":"Shademan","year":"2022","journal-title":"J. Ardabil Univ. Med. Sci."},{"key":"10.1016\/j.msard.2024.106237_bib0083","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jocn.2020.04.071","article-title":"Investigation of the miRNA146a and miRNA155 gene expression levels in patients with multiple sclerosis","volume":"78","author":"Shademan","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0084","doi-asserted-by":"crossref","first-page":"419","DOI":"10.34172\/apb.2024.024","article-title":"Methylglyoxal Affects the Expression of miR-125b, miR-107, and Oxidative Stress Pathway-associated Genes in the SH-SY5Y Cell Line","volume":"14","author":"Shademan","year":"2024","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.msard.2024.106237_bib0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jns.2017.11.014","article-title":"Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases","volume":"383","author":"Sharaf-Eldin","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0086","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000420","article-title":"microRNAs in neurodegeneration: current findings and potential impacts","volume":"8","author":"Sharma","year":"2018","journal-title":"J Alzheimers Dis. Parkinsonism"},{"key":"10.1016\/j.msard.2024.106237_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0316-0","article-title":"Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases","volume":"9","author":"Sheinerman","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.msard.2024.106237_bib0089","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.0000000000006583","article-title":"Misdiagnosis of multiple sclerosis: impact of the 2017 McDonald criteria on clinical practice","volume":"92","author":"Solomon","year":"2019","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/1352458520910496","article-title":"Challenges in multiple sclerosis diagnosis: misunderstanding and misapplication of the McDonald criteria","volume":"27","author":"Solomon","year":"2021","journal-title":"Multiple Scler. J."},{"issue":"4","key":"10.1016\/j.msard.2024.106237_bib0091","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.celrep.2019.09.020","article-title":"Oligodendrocyte intrinsic miR-27a controls myelination and remyelination","volume":"29","author":"Tripathi","year":"2019","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.msard.2024.106237_bib0092","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/1352458516651141","article-title":"Circulating microRNAs as biomarkers in progressive multiple sclerosis","volume":"23","author":"Vistbakka","year":"2017","journal-title":"Multiple Sclerosis J."},{"issue":"4","key":"10.1016\/j.msard.2024.106237_bib0093","first-page":"988","article-title":"Epidemiology and pathophysiology of multiple sclerosis","volume":"28","author":"Ward","year":"2022","journal-title":"Continuum"},{"key":"10.1016\/j.msard.2024.106237_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106733","article-title":"Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment","volume":"190","author":"Yi","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.msard.2024.106237_bib0095","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/08820139.2021.1887888","article-title":"Serum based miRNA as a diagnostic biomarker for multiple sclerosis: a systematic review and meta-analysis","volume":"51","author":"Zailaie","year":"2022","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.msard.2024.106237_bib0096","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1226130","article-title":"MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study","volume":"14","author":"Zangh\u00ec","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2024.106237_bib0097","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neurol.2018.03.006","article-title":"Progress in understanding the pathophysiology of multiple sclerosis","volume":"174","author":"Z\u00e9phir","year":"2018","journal-title":"Rev. Neurol. (Paris)"},{"issue":"5","key":"10.1016\/j.msard.2024.106237_bib0098","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuron.2010.02.018","article-title":"MicroRNA-mediated control of oligodendrocyte differentiation","volume":"65","author":"Zhao","year":"2010","journal-title":"Neuron."},{"issue":"2","key":"10.1016\/j.msard.2024.106237_bib0099","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10753-017-0705-3","article-title":"MiR-548a-3p promotes keratinocyte proliferation targeting PPP3R1 after being induced by IL-22","volume":"41","author":"Zhao","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.msard.2024.106237_bib0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fneur.2020.00132","article-title":"A meta-analytic review of the value of miRNA for multiple sclerosis diagnosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824008137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824008137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:48:37Z","timestamp":1741841317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824008137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":98,"alternative-id":["S2211034824008137"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.106237","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA frontiers: Illuminating early detection paths in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.106237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106237"}}